{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.3616.200.110.102.4014","meta":{"versionId":"5","lastUpdated":"2020-08-18T10:21:27.000-04:00"},"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.4014","version":"20200722","name":"COVID19 ICD10PCS Value Set for Administration of Immunosuppressive Therapy","status":"active","date":"2020-07-22T01:00:33-04:00","publisher":"Clinical Architecture","compose":{"include":[{"system":"http://www.icd10data.com/icd10pcs","version":"2022","concept":[{"code":"3E030WL","display":"Introduction of Immunosuppressive into Peripheral Vein, Open"},{"code":"3E033WL","display":"Introduction of Immunosuppressive into Peripheral Vein, Percutaneous"},{"code":"3E040WL","display":"Introduction of Immunosuppressive into Central Vein, Open"},{"code":"3E043WL","display":"Introduction of Immunosuppressive into Central Vein, Percutaneous"},{"code":"3E050WL","display":"Introduction of Immunosuppressive into Peripheral Artery, Open"},{"code":"3E053WL","display":"Introduction of Immunosuppressive into Peripheral Artery, Percutaneous"},{"code":"3E060WL","display":"Introduction of Immunosuppressive into Central Artery, Open"},{"code":"3E063WL","display":"Introduction of Immunosuppressive into Central Artery, Percutaneous"},{"code":"XW03351","display":"Introduction of Blinatumomab Antineoplastic Immunotherapy into Peripheral Vein, Percutaneous Approach, New Technology Group 1"},{"code":"XW04351","display":"Introduction of Blinatumomab Antineoplastic Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 1"}]}]},"expansion":{"identifier":"urn:uuid:f813455c-d430-4fed-96bb-c8e8ab7c15d0","timestamp":"2022-06-10T06:23:31-04:00","total":8,"offset":0,"parameter":[{"name":"count","valueInteger":1000},{"name":"offset","valueInteger":0}],"contains":[{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E030WL","display":"Introduction of Immunosuppressive into Peripheral Vein, Open"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E033WL","display":"Introduction of Immunosuppressive into Peripheral Vein, Percutaneous"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E040WL","display":"Introduction of Immunosuppressive into Central Vein, Open"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E043WL","display":"Introduction of Immunosuppressive into Central Vein, Percutaneous"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E050WL","display":"Introduction of Immunosuppressive into Peripheral Artery, Open"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E053WL","display":"Introduction of Immunosuppressive into Peripheral Artery, Percutaneous"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E060WL","display":"Introduction of Immunosuppressive into Central Artery, Open"},{"system":"http://www.icd10data.com/icd10pcs","version":"2022","code":"3E063WL","display":"Introduction of Immunosuppressive into Central Artery, Percutaneous"}]}}